XML 40 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments and Geographic Information
 12 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic InformationThe Company reports segment information in accordance with ASC 280, Segment Reporting. Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company’s chief operating decision maker is its chief executive officer, and the Company’s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable products and supplies, primarily used for diagnostic testing and surgical procedures. The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense and goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.
Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2023, 2022, and 2021 was as follows:
 Years ended
 September 30,
2023		September 24,
2022		September 25,
2021
Total revenues:
Diagnostics$1,880.1 $3,018.5 $3,695.0 
Breast Health1,432.7 1,227.8 1,352.3 
GYN Surgical604.2 522.9 488.1 
Skeletal Health113.4 93.6 96.9 
$4,030.4 $4,862.8 $5,632.3 
Operating income (loss):
Diagnostics$193.9 $1,359.4 $2,140.1 
Breast Health273.0 183.2 284.2 
GYN Surgical188.9 104.9 58.9 
Skeletal Health12.6 (7.3)(2.9)
$668.4 $1,640.2 $2,480.3 
Depreciation and amortization:
Diagnostics$224.7 $274.0 $260.4 
Breast Health50.0 58.8 52.7 
GYN Surgical48.0 96.6 93.1 
Skeletal Health0.7 0.7 0.7 
$323.4 $430.1 $406.9 
Capital expenditures:
Diagnostics$85.2 $96.8 $147.7 
Breast Health41.1 14.6 14.2 
GYN Surgical17.0 12.8 14.5 
Skeletal Health0.8 0.3 0.3 
Corporate6.1 2.7 1.0 
$150.2 $127.2 $177.7 
Identifiable assets:
Diagnostics$2,596.4 $2,881.7 $3,348.8 
Breast Health1,170.1 1,245.8 1,233.9 
GYN Surgical1,455.4 1,461.5 1,369.7 
Skeletal Health33.7 27.5 31.9 
Corporate3,883.7 3,454.7 2,935.6 
$9,139.3 $9,071.2 $8,919.9 
 

The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy, and the Netherlands. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of world” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 Years ended
 September 30,
2023		September 24,
2022		September 25,
2021
United States75.9 %71.3 %69.3 %
Europe12.9 %18.3 %21.3 %
Asia-Pacific6.3 %7.4 %6.5 %
Rest of world4.9 %3.0 %2.9 %
100.0 %100.0 %100.0 %

        The Company’s property, plant and equipment were geographically located as follows:
September 30, 2023September 24, 2022September 25, 2021
United States$367.6 $332.4 $403.2 
Europe67.0 72.1 85.8 
Costa Rica36.0 32.1 26.9 
United Kingdom
32.4 31.7 37.1 
Rest of world14.0 13.3 11.7 
$517.0 $481.6 $564.7